Reporting owner · CIK 0001231589

Mahon Paul A

Visual SEC Form 4 history across 1 companies, 93 transactions and 14 filings.

EVP, GCEVP & GENERAL COUNSELUNITED THERAPEUTICS Corp
Open-market mix
Latest filingAug 21, 2026, 08:43 PM
Filings14Form 4 records
Buying$00 purchases
Selling$28.6M53 sales
Net value−$28.6MBuys minus sells
Companies15 securities
Most recentAug 20, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
20100-10-20Mar 23Jan 25Feb 25Mar 2514Jan 2614Feb 2616Mar 269Aug 26

Net value flow

Buys minus sells

Mar 23
$0
Jan 25
$0
Feb 25
$0
Mar 25
$0
Jan 26
−$7.9M
Feb 26
−$8M
Mar 26
−$8.4M
Aug 26
−$4.3M

Transaction texture

Ownership and ticket size

Average P/S size$540.5K
Median P/S size$452.9K
Direct93
Indirect0
Aug 20, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern37Delayed Filingfiling-context3Derivative Transactionfiling-context17Direct Ownershipfiling-context83Large Holdings Increaseholdings3Large Holdings Reductionholdings5Large Salesize6Repeat Sellerpattern4310b5-1 Detectedfiling-context74

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at UNITED THERAPEUTICS Corp on Aug 20, 2026 valued at $63,265.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at UNITED THERAPEUTICS Corp on Aug 20, 2026 valued at $63,265.

Review SEC filing

Associated companies

Visual map of known reporting history

UTHRUNITED THERAPEUTICS Corp93 transactions · latest Aug 21, 2026, 08:43 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
UTHRMAHON PAUL A
EVPGC
exercise10b5-15.61k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
exercise10b5-12.69k$0M
Derivative Transaction Direct Ownership 10b5-1 Detected
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1120-$6.32MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1400-$21.0MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1940-$49.3MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1192-$10.0MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1850-$44.4MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1787-$41.0MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-11.81k-$94.7MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20
UTHRMAHON PAUL A
EVPGC
sale10b5-1502-$26.1MS
Cluster Selling Direct Ownership Repeat Seller+1
+0.5%08/2108/20

Mahon Paul A Insider Activity FAQ

SEC Form 4 context

Who is Mahon Paul A?

Mahon Paul A is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001231589.

Which companies has Mahon Paul A reported transactions for?

UNITED THERAPEUTICS Corp

When was Mahon Paul A's latest insider buy?

No open-market insider purchase is available for this period.

When was Mahon Paul A's latest insider sale?

sale at UNITED THERAPEUTICS Corp on Aug 20, 2026 valued at $63,265.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.